Exelixis
EXEL
EXEL
346 hedge funds and large institutions have $5.08B invested in Exelixis in 2019 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 136 increasing their positions, 110 reducing their positions, and 66 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
346
Holders Change
-31
Holders Change %
-8.22%
% of All Funds
7.53%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
42
Increased
136
Reduced
110
Closed
66
Calls
$86.7M
Puts
$57.5M
Net Calls
+$29.2M
Net Calls Change
-$48.9M
Top Buyers
| 1 |
Renaissance Technologies
New York
|
$288M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
$82.9M |
| 3 |
Nuveen Asset Management
Chicago,
Illinois
|
$47.3M |
| 4 |
O
OrbiMed
New York
|
$83.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$131M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$351M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
$293M |
| 3 |
Wells Fargo
San Francisco,
California
|
$23.2M |
| 4 |
JPMorgan Chase & Co
New York
|
$171M |
| 5 |
Goldman Sachs
New York
|
$106M |
